Eligibility
Applicant type, geography, program rules and required conditions.
My Organization Fit Score
See how strongly this opportunity fits your organization.
Atlas combines public grant intelligence with the details of your organization to evaluate eligibility, strategic alignment, funding potential, timing, project fit and submission burden.
GrantFlorida — DCF RFP 2627 020 Emergency Opioid Antagonist Products and Resources
Atlas Opportunity Score74/100
FundingNo verified contract ceiling or guaranteed procurement amount was identified in the sources reviewed.
DeadlineCurrent MFMP-derived deadline: November 10, 2026. Exact clock time/time zone not independently recovered from Addendum No. 03.
Required next actionQualified pharmaceutical manufacturers/distributors should review the live MFMP package and all addenda, confirm the exact November 10 response time, and validate every product, logistics, portal, reporting, and compliance requirement before bidding. Dr. Miltie should not pursue prime status without documented qualification for the full pharmaceutical/distribution scope.
Current statusOpenSource verification2026-09-11
Tell Atlas Who You Are
Request your organization-specific analysis.
The form will carry the grant context with it, so you only need to provide the details Atlas cannot know from the opportunity itself.
How Atlas Scores Fit
Useful enough to guide action, structured enough to scale.
Strategic Alignment
How directly the organization's goals and use case match the funder's priorities.
Funding Potential
Available dollars, allowable uses, match burden and the amount that can realistically support the project.
Actionability
Deadline, documentation burden, readiness and the practical work required to submit a strong application.
A High Score Is the Beginning
When the fit is strong, Atlas shows you why.
The goal is not to hand you another number. It is to identify the opportunities worth your attention and make the next step obvious.